Abstract:Gprotein-coupled receptors (GPCRs) regulate several physiological and pathological processes and represent the target of approximately 30% of Food and Drug Administration-approved drugs. GPCR-mediated signaling was thought to occur exclusively at the plasma membrane. However, recent studies have unveiled their presence and function at subcellular membrane compartments. There is a growing interest in studying compartmentalized signaling of GPCRs. This requires development of tools to separate GPCR signaling at the plasma membrane from the ones initiated at intracellular compartments. We leveraged the structural and pharmacological information available for β-adrenergic receptors (βARs) and focused on β1AR as exemplary GPCR that functions at subcellular compartments, and rationally designed spatially restricted antagonists. We generated a cell-impermeable βAR antagonist by conjugating a suitable pharmacophore to a sulfonate-containing fluorophore. This cell-impermeable antagonist only inhibited β1AR on the plasma membrane. In contrast, a cell-permeable βAR antagonist containing a nonsulfonated fluorophore efficiently inhibited both the plasma membrane and Golgi pools of β1ARs. Furthermore, the cell-impermeable antagonist selectively inhibited the phosphorylation of PKA downstream effectors near the plasma membrane, which regulate sarcoplasmic reticulum (SR) Ca2+ release in adult cardiomyocytes, while the β1AR Golgi pool remained active. Our tools offer promising avenues for investigating compartmentalized βAR signaling in various contexts, potentially advancing our understanding of βAR-mediated cellular responses in health and disease. They also offer a general strategy to study compartmentalized signaling for other GPCRs in various biological systems.

GPCR signalling from within the cell

Compartmentalized GPCR Signaling from Intracellular Membranes

Distinct Conformations of GPCR–β-arrestin Complexes Mediate Desensitization, Signaling, and Endocytosis

Subcellular location defines GPCR signal transduction

GPCRs in Autocrine and Paracrine Regulations

Pharmacologically Targeting Intracellular Allosteric Sites of GPCRs for Drug Discovery.

G Protein–Coupled Receptor (GPCR) Expression in Native Cells: “Novel” endoGPCRs as Physiologic Regulators and Therapeutic Targets

Mechanisms of signalling and biased agonism in G protein-coupled receptors

Toward a Structural Understanding of Class B GPCR Peptide Binding and Activation.

Cannabinoid Receptor Signaling is Dependent on Sub-Cellular Location

Therapeutic Targeting of Endosomal G-Protein-Coupled Receptors

GPCR oligomers in pharmacology and signaling

Functionally Distinct and Selectively Phosphorylated GPCR Subpopulations Co-Exist in a Single Cell

Subcellular activation of β-adrenergic receptors using a spatially restricted antagonist

GPCR Biosensors to Study Conformational Dynamics and Signaling in Drug Discovery

Subcellular localization of GPCR kinases differentially modulate biased signaling at CXCR3

Molecular Mechanisms of GPCR Signaling: A Structural Perspective

The expansion of GPCR transactivation-dependent signalling to include serine/threonine kinase receptors represents a new cell signalling frontier

Studying GPCR Pharmacology in Membrane Microdomains: Fluorescence Correlation Spectroscopy Comes of Age

Structure, function and drug discovery of GPCR signaling

Beyond the Cell Surface: New Mechanisms of Receptor Function